Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection - eClinicalMedicine
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production - ScienceDirect
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES - Chiara Zecca, Claudio Gobbi, 2022
Antibodies | Free Full-Text | Monoclonal Antibodies in Cancer Therapy
How Long Does Immunity To COVID-19 Last? : Goats and Soda : NPR
Anti-SARS-CoV-2 Monoclonal Antibodies
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England - The
Switchable assembly and function of antibody complexes in vivo using a small molecule | PNAS
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications
Antibodies | Free Full-Text | Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling | National Institutes of Health (NIH)
Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells
Affinity maturation for an optimal balance between long-term immune coverage and short-term resource constraints | PNAS
Frontiers | Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
The humoral response and antibodies against SARS-CoV-2 infection | Nature Immunology
Pharmaceutics | Free Full-Text | Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein ...
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells - ScienceDirect
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses | ACS Nano
A long-term perspective on immunity to COVID
Antibody - Wikipedia
